Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.
Pubmed ID: 15264177
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Publication Date: Aug. 1, 2004
MeSH Terms: Humans, Male, Female, Aged, Aged, 80 and over, Cardiovascular Diseases, Risk Factors, United States, Middle Aged, Longitudinal Studies, Coronary Disease, Follow-Up Studies, Comorbidity, Incidence, Stroke, Socioeconomic Factors, Kidney Diseases, Mortality, Myocardial Infarction, Sensitivity and Specificity, Kidney Function Tests, Recurrence, Hyperlipidemias, Ethnicity
Grants: T32DK007777, R01DK53689, K23 02904
Authors: Tighiouart H, Weiner DE, Salem DN, Levey AS, Sarnak MJ, MacLeod B, Amin MG, Stark PC, Griffith JL
Cite As: Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004 Aug;44(2):198-206.
Studies:
Abstract
BACKGROUND: Chronic kidney disease (CKD) is highly prevalent in the United States and is an independent risk factor for adverse cardiovascular disease (CVD) and all-cause mortality outcomes in patients with acute coronary syndromes. Few studies have evaluated the effect of CKD on cardiovascular events in a diverse community-based population with underlying CVD. METHODS: Data for subjects with preexisting CVD were pooled from 4 publicly available, community-based, longitudinal studies: Atherosclerosis Risk in Communities, Cardiovascular Health Study, Framingham Heart Study, and Framingham Offspring Study. CKD was defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2 (<1 mL/s/1.73 m2). The primary study outcome was a composite of myocardial infarction (MI), fatal coronary heart disease (CHD), stroke, and all-cause mortality. The secondary outcome included only MI and fatal CHD. RESULTS: A total of 4,278 subjects satisfied inclusion criteria, and 759 subjects (17.7%) had CKD. Mean follow-up was 86 months. The primary and secondary outcomes were observed in 1,703 (39.8%) and 857 subjects (20.0%), respectively. Incidence rates for the primary and secondary outcomes were greater in persons with CKD compared with those without CKD (62.5% versus 34.9% and 30.6% versus 17.8%, respectively). Adjusted hazard ratios for the primary and secondary outcomes were 1.35 (95% confidence interval [CI], 1.21 to 1.52) and 1.32 (95% CI, 1.12 to 1.55), respectively. CONCLUSION: The presence of CKD in a community-based population with preexisting CVD is associated with an increased risk for recurrent CVD outcomes. This increased risk persists after adjustment for traditional CVD risk factors.